mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |